Trinity Biotech PLC
NASDAQ:TRIB

Watchlist Manager
Trinity Biotech PLC Logo
Trinity Biotech PLC
NASDAQ:TRIB
Watchlist
Price: 0.7913 USD 12.43% Market Closed
Market Cap: 15.2m USD

Operating Margin

-26.1%
Current
Improving
by 3.4%
vs 3-y average of -29.5%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-26.1%
=
Operating Income
$-16.1m
/
Revenue
$61.6m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-26.1%
=
Operating Income
$-16.1m
/
Revenue
$61.6m

Peer Comparison

Country Company Market Cap Operating
Margin
IE
Trinity Biotech PLC
NASDAQ:TRIB
15.2m USD
Loading...
US
Abbott Laboratories
NYSE:ABT
188.9B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.5B USD
Loading...
US
Stryker Corp
NYSE:SYK
137.1B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.3B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129.9B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.8B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
49.3B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.3B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
49B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.3B USD
Loading...

Market Distribution

Lower than 90% of companies in Ireland
Percentile
10th
Based on 294 companies
10th percentile
-26.1%
Low
-5 292.3% — 0.1%
Typical Range
0.1% — 13.7%
High
13.7% — 178.8%
Distribution Statistics
Ireland
Min -5 292.3%
30th Percentile 0.1%
Median 9.5%
70th Percentile 13.7%
Max 178.8%

Trinity Biotech PLC
Glance View

Market Cap
15.2m USD
Industry
Health Care

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. The company is headquartered in Bray, Wicklow. The firm's products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the liver and intestine. The company operates through two segments: the Americas and Rest of World. Its products are classified as POC, emergency medicine, clinical laboratory and blood bank screening. Its POC brands include Uni-Gold and Recombigen. Emergency medicine diagnostics refer to its acute care testing, STAT labs, pre/post-operative units, physician office labs and the central laboratory. Trinity Biotech supplies clinical laboratory market with reagent products and other products through its clinical chemistry business.

TRIB Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-26.1%
=
Operating Income
$-16.1m
/
Revenue
$61.6m
What is Trinity Biotech PLC's current Operating Margin?

The current Operating Margin for Trinity Biotech PLC is -26.1%, which is above its 3-year median of -29.5%.

How has Operating Margin changed over time?

Over the last 3 years, Trinity Biotech PLC’s Operating Margin has decreased from 8% to -26.1%. During this period, it reached a low of -46.1% on Mar 31, 2024 and a high of 8% on Dec 31, 2021.

Back to Top